Medical News Today3d
Calorie restriction plus common diabetes drug leads to higher remission rates
A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...
Hosted on MSN3h
Nearly 7,000 Bottles of a Heart and Diabetes Medication Recalled in At Least One State
Around 20 million Americans reportedly trust this medication—here are the recall details, and the unusual error that caused ...
Rolling Out4d
Breakthrough diabetes drug slashes dementia risk by 35%
New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...
Rolling Out6d
How diabetes medications could change stroke prevention
Learn how diabetes medications could revolutionize stroke prevention and enhance heart and brain health with breakthrough ...
FDA approves Novo Nordisk's diabetes drug Ozempic for chronic kidney disease, expanding use in U.S.
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
McKnight's Long-Term Care News1d
FDA expands Ozempic to treat kidney disease in people with diabetes
The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...
GlobalData on MSN2d
Novo Nordisk secures FDA approval for Ozempic in diabetes with CKD
The US Food and Drug Administration (FDA) has approved Novo Nordisk’s Ozempic (semaglutide) to reduce certain risks ...